Navigation Links
Advancing Interoperability - Nonin(R) Medical Unveils World's First Bluetooth(R)-Enabled, Wireless Fingertip Pulse Oximeter
Date:4/8/2008

MINNEAPOLIS, April 8, 2008 /PRNewswire/ -- Nonin Medical, Inc., in an effort to address rising healthcare costs and promote the use of remote monitoring, unveiled the world's first fingertip oximeter with Bluetooth wireless technology at the American Telemedicine Association (ATA) meeting in Seattle, WA. The revolutionary Onyx(R) II, Model 9560 fingertip pulse oximeter is designed for interoperability, meeting the requirements of the emerging Medical Device Profile (MDP), IEEE11073 and Continua compliance standards. With this innovation, Nonin Medical's commitment is to simplify healthcare delivery by providing innovative solutions that enable patients, such as those with chronic conditions, and clinicians to easily and cost-effectively manage monitored information.

One area of healthcare that stands to benefit greatly from wireless physiological monitoring devices is chronic disease management. Breakthrough devices such as the Onyx II, Model 9560 will enable patients and healthcare professionals alike. Patients who suffer from diseases such as Chronic Obstructive Pulmonary Disease (COPD), Congestive Heart Failure (CHF) or Asthma will be able to regain independence -- living healthier lives. The environment where vital signs can be easily monitored by the patient and sent wirelessly through communication devices (cell phones, PDAs, PCs, etc.) creates freedom like never before.

"With the rapidly rising cost of healthcare and the ever-growing strain put on healthcare facilities, there is tremendous pressure for a streamlined solution that simplifies the exchange of information and promotes patient participation," said Gary Tschautscher, President and C.E.O. of Nonin Medical. "The integration of interoperable, Bluetooth wireless technology in health monitoring devices will provide patients and clinicians the ability to monitor vital signs with much greater ease and flexibility."

Since its release in 1995, Onyx(R) has become the most trusted
'/>"/>

SOURCE Nonin Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Home Healthcare Reimbursement Freeze is Barrier to Commonwealth Goal of Advancing Alternative Care
2. Six Olympic Legends Battling Chronic Diseases Lead Revolution in Advancing Pharmacy Care as Medco Launches the Tour of Champions
3. Nonin Medical, Inc. Is Recognized for Its Role in Promoting Interoperability
4. Greenway Medical Technologies Strengthens Industry Leadership With Participation in the IHE Connectathon and HIMSS Interoperability Showcase
5. Global Interoperability and Patient Privacy Focus of New Liberty Alliance Health Identity Management Group
6. Accenx Technologies Brings Healthcare IT Solutions to HIMSS08 Interoperability Showcase
7. CAQH Core Rules Final Component of HITSP Interoperability Standards Formally Recognized By HHS Sec. Leavitt
8. EHRVA Members Collaborate to Demonstrate Interoperability Success at NCHICA
9. Rising Medical Solutions and WorkCompEDI Establish Relationship to Provide Workers Compensation eBilling Solutions
10. Metrologic and Wake Forest University Baptist Medical Center Sponsored Healthcare Educational Forum
11. Dr. William S. Gruss, M.D., Says That Medical Research Shows You Can Reduce Your Risk of Cancer By Up To 77% and Reverse the Effects of Aging in A CARDIOLOGISTS GUIDE TO ... ANTI-AGING, ANTIOXIDANTS & RESVERATROL

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... in eventual development of screening test, resear...thDay News) -- New research points to the possibil...disease. , People with high blood pressure who ...on in the body were found to be twice as likely as...t failure, the study found. , The finding may l...
(Date:12/3/2009)...ONT, Calif., Dec. 3 The...eleased findings today from one of the largest stu...in women conducted by the Northern California Can...at women who never smoked cigarettes and who were ...ime--especially during adulthood--had a significan...
(Date:12/3/2009)... JOLLA, Calif., Dec. 3 ...iological Studies unanimously voted to elect thre...la. ,, Fred Dotzler is co-founder and Managin.... De Novo is investing $650 million from three fun... companies. Dotzler founded Medicus Venture Partne...
(Date:12/3/2009)...PASADENA, Calif., Dec. 3 For Calif... the risk of disability remains one of the most si...cial well being, but also their business,s viabili...ave taken their toll, owners of small businesses a...l safety net with enhanced disability coverage," s...
(Date:12/3/2009)...RASOTA, Fla., Dec. 3 If you have s...t ready for a stunning look at the other side of t...od will screen her feature documentary, "Superchar...ay, December 8th, 5 p.m. at Sever Hall, Harvard Ya...iving" College Tour. The film will be followed by ...
Breaking Medicine News(10 mins):Health News:Vitamin D May Be Tied to Heart Disease Via Genes 2Health News:Northern California Cancer Center's Findings on Breast Cancer and Secondhand Smoke Released Internationally by the American Association for Cancer Research 2Health News:Salk Institute Board of Trustees Elects Leaders in Venture Capital and Publishing to its Membership 2Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 2Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 3Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 4Health News:Jenna Norwood to Present Award-Winning Documentary & Lecture at Harvard University 2
...inal Health, a global provider of products and ser...health care, today launched nine new products targ...perating rooms, including high-performance surgica...urgical scrubs market , Cardinal Health is enteri...
...Tools, Inc. is happy to announce the birth of Clin...ns developed exclusively to assist healthcare prov...nic Medical Record (EMR) designed to serve as a tr...e providers. , , ClinicTools(R) makes it easier ...
...e the Way People Think About End-of-Life , , Rece...er Ken Burns , , DETROIT, March 17 Hospice of Mi...pice organizations, has produced a documentary fil...- 5:30 pm. For television channels, see the tele...
... now just a phone call away for parents, pediatric...al professionals caring for any child in Ohio with...ess. , , The Comfort Line is a medical advice and... , Toll-free phone calls are accepted Monday throu...
...n syringes are the oldest delivery method availabl...e in Europe. Several factors have contributed to t...tance and popularity of insulin pens. , , (Logo:...n Insulin Delivery Devices Market , finds that the...
...st Listen is a newly launched service that provide...oking to talk, vent or just share what,s on their ...B) March 17, 2009 -- The stock market is in the ta...ut words not everyone may want to hear. Now, peopl...
Other Medicine News:Health News:Cardinal Health Launches New Products for the Operating Room 2Health News:Cardinal Health Launches New Products for the Operating Room 3Health News:Cardinal Health Launches New Products for the Operating Room 4Health News:Cardinal Health Launches New Products for the Operating Room 5Health News:Electronic Medical Record of the Future Is Here 2Health News:Hospice of Michigan Documentary to Air on Detroit Public Television Monday, March 23 and Sunday, March 29 2Health News:'Comfort' Now Available to Caregivers of Ohio's Seriously-Ill Children 2Health News:Insulin Pens and Growing Diabetic Community Increase Market for Insulin Delivery Devices in Europe, Says Frost & Sullivan 2Health News:Insulin Pens and Growing Diabetic Community Increase Market for Insulin Delivery Devices in Europe, Says Frost & Sullivan 3Health News:Insulin Pens and Growing Diabetic Community Increase Market for Insulin Delivery Devices in Europe, Says Frost & Sullivan 4Health News:Confidential Listening Service We Just Listen Launches, Providing Americans a Private Platform to Express Their Thoughts and Feelings 2
(Date:12/3/2009)... HOERSHOLM, Denmark and SAN DIEGO, California, Dec...ssfully Inhibits miR-122, a microRNA Important for...tly Reducing Hepatitis C,Virus in the Bloodstream ...itis C Virus , - SPC3649 Demonstrates Eff...Serious Adverse Events in the Treated Animals - Si...
(Date:12/3/2009)... Dec. 3 Cardium Therapeu...holly-owned subsidiary, Tissue Repair Company, sub... the U.S. Food and Drug Administration (FDA) seeki...duct candidate based on positive data from the Com... study. Today,s submission with the FDA covers Ex...
(Date:12/3/2009)...alif., Dec. 3 Jazz Pharm...that Kathryn E. Falberg has been appointed Senior ...alberg brings to Jazz Pharmaceuticals more than 20...e. As Jazz Pharmaceutical,s CFO, Ms. Falberg will...orate finance, financial planning, investor relati...
Breaking Medicine Technology:New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 2Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 4Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 5Weight Watchers 28R 29 Launches New Community on WeightWatchers com 55510 1Weight Watchers 28R 29 Launches New Community on WeightWatchers com 55510 2Weight Watchers 28R 29 Launches New Community on WeightWatchers com 55510 3Get Ready for Gruesome Cigarette Warnings 55508 1Get Ready for Gruesome Cigarette Warnings 55508 2Get Ready for Gruesome Cigarette Warnings 55508 3Mindray Medical to Participate in the SIG Third Annual Beijing Management Summit 55505 1Mindray Medical to Participate in the SIG Third Annual Beijing Management Summit 55505 2
...Form Medical,Inc. (Nasdaq: BFRM ) today announced...nded comparative study of nasolabial fold treatmen...Radiesse(R) dermal filler,than reported after trea...results of this study were published in the Decemb...c Surgery, a peer-reviewed publication of the,Amer...
...ent in Motor Function at 24 Months, SAN DIEGO, De...llow-up data from a Phase 1 clinical trial of CERE...ase. CERE-120 uses gene therapy to,deliver the neu...eurodegeneration that occurs in the brains of Park...ssments at 18 and 24 months post,treatment, sugges...
Other Medicine Technology:Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 2Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 3Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 4Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 5Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 6Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinson's Disease 2Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinson's Disease 3Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinson's Disease 4
Streck-Kleen Enzymatic Cleanser
Streck-Diluent III Plus Balanced Electrolyte Solution
Streck-CN free Lyse CD Lytic Reagent
...ted red blood cell (nRBC) control for evaluating t... 755 hematology analyzer in its enumeration of the...r LH 750/LH 755. nRBC-Chex for LH is a two-level c...nRBC-Chex for LH has a 75-day closed-vial stabilit...
Medicine Products: